Published by Coherent Market Insights
Posted on September 16, 2021
4 min readLast updated: February 9, 2026
Add as preferred source on Google
Near Patient Molecular Solution Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Abbott Laboratories, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., and GenMark Diagnostics.
Near patient molecular solutions, also known as point-of-use diagnosis, is an innovative technology which helps to diagnose and measure health in the very private and personal comfort of the individual. The main motive is to offer patients easy access to necessary testing services, with fast turnaround times and accurate outcomes as compared to that provided by traditional laboratory-based tests. This diagnostic method helps to maintain a healthy environment at all times, even while undergoing medical procedures. It is extremely helpful in detecting any health conditions beforehand, before any such conditions cause severe discomfort to a patient. In June 2021, a major diagnostic testing solutions provider, Meridian BioScience, launched the Lyo-Ready RT-LAMP Mix for molecular detection of RNA viruses.
Request Here For Market Latest Insights: https://www.coherentmarketinsights.com/insight/request-pdf/47
In recent years, near patient molecular solutions have emerged to address the medical concerns of individuals living in different regions and diseases affecting the human body. The main purpose of these products is to monitor the health of an individual as he or she travels across regions or crosses the border from one country to another. Depending on the disease concerned, the products are designed to be compatible with the standards of the healthcare organization of the country from where the individual has moved. The products are made available for use in clinical trials conducted by pharmaceutical companies and other institutions. In June 2021, the diagnostic testing company, BGI Americas, partnered with Advaite, a bio-tech company, to enhance the molecular testing solutions of the former.
Some of the factors pushing the near patient molecular solution market are increased use of residence point-of-care equipment, technological advancements with a trend for quicker and easier-to-use devices, and the rising rates of illnesses such as heart disease and diabetes in emerging nations. Additionally, the near patient molecular solution market is being propelled by the higher demand for home healthcare services and an increase in the number of geriatric patients with various chronic diseases.
Based on regions, North America led the near patient molecular solution market in the view of favorable reimbursement rules for diagnostic techniques and a large number of clinical trials examining the efficacy. Similarly, the lack of clinical diagnosing facilities have paved a way for local participants to provide near patient monitoring in the Asia Pacific region, which is projected to broaden the growth aspects of the near patient molecular solution market.
However, due to a decrease in the number of patient visits and the fact that hospitals have redirected their healthcare supplies and priority to the administration of COVID-19 cases, there has been a considerable drop in demand for regular diagnostic testing equipment or kits.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/47
Reasons to Purchase this Report
• Current and future of global Near Patient Molecular Solution Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Near Patient Molecular Solution Market to Exhibit Skyrocketing Expansion During 2021-2027 appeared first on Gatorledger.
Near patient molecular solutions, also known as point-of-use diagnosis, is an innovative technology that helps diagnose and measure health in the comfort of the individual's own environment.
Factors pushing the near patient molecular solution market include increased use of residence point-of-care equipment and technological advancements aimed at quicker and easier-to-use devices.
North America leads the near patient molecular solution market due to favorable reimbursement rules for diagnostic techniques and a significant number of clinical trials examining these solutions.
The COVID-19 pandemic has led to a decrease in patient visits and caused hospitals to redirect their healthcare supplies and priorities towards managing COVID-19 cases, impacting the near patient molecular solution market.
The market for near patient molecular solutions is expected to exhibit significant expansion from 2021 to 2027, driven by advancements in technology and increasing demand for point-of-care diagnostics.
Explore more articles in the Research Reports category
